RPHPROSTAPET (PSMA)

PSMA-11

Presentation: Kits containing 1 freeze-dried vial containing the peptide. The product is sterile, apyrogenic, and under nitrogen atmosphere. Contains a Solution Kit for labeling with the 68Ga with:7 solution vial for injectable use, 2 empty vials and 1 vial for generator’s cleansing.

Indications: Used for diagnosing patients with prostate cancer and metastasis detection.

Storage: Peptides box: from -15 °C to -25 °C.

Solutions: 2 – 8 °C.
Postlabeling activity: 0.05 to 0.06 mCi/kg.

Postlabeling stability: until 2 hours in room temperature (15 °C – 30 °C).
Expiry date: 12 months.
Number of bottles per kit: 1 + 10
Contraindications, warnings and precautions, drug dose:  see the package insert.

RPHPharma products are available only under prescription by a licensed health professional.

The content of this page is intended for health professionals.

Menu